Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial.

Minoo MohrazKatayoun VahdatSeyyed-Hadi GhamariMohsen Abbasi-KangevariErfan GhasemiYasaman GhabdianNegar RezaeiMaryam Amini PouyaAsghar AbdoliMohammad-Reza MalekpourKeyvan KoohgirSahar Saeedi MoghaddamPayam TabarsiMohsen MoghadamiFarzin KhorvashRozita KhodashahiMohammadreza SalehiHamed Hosseini

Published in: BMJ (Clinical research ed.) (2023)

Shifa-Pharmed Industrial Group.

Keyphrases

double blind
placebo controlled
sars cov
clinical trial
phase ii
phase iii
study protocol
wastewater treatment
respiratory syndrome coronavirus
heavy metals
phase ii study
open label
squamous cell carcinoma